- This event has passed.
The Global Threat of Antibiotic Resistance: The Truth and the Path Ahead
02/12/2015 @ 5:30 PM - 9:00 PM
Please join us for a panel discussion with world leading researchers from Uppsala University on antibiotic resistance and how it affects the general population, the current response from a policy and advocacy perspective, and potential new drugs. Uppsala University is widely considered one of the leading European research institutions in this area.
As reported by the World Health Organization, “It is an increasingly serious threat to global public health that requires action across all government sectors and society.” After discussion on cutting edge research, an extended Q&A session will follow so please bring your questions.
To register, please contact Anne Tang by Friday, February 6.
This program, organized by American Friends of Uppsala University, is complimentary. Wine and hors d’oeuvres will be served.
Diarmaid Hughes, Professor of Medical Molecular Bacteriology, Uppsala University
Diarmaid Hughes has a PhD in Genetics from Trinity College Dublin, and moved to Sweden in 1985. His research interests are focused on genetics, evolution and growth physiology, using bacteria as a model system. In recent years he has increasingly worked on the evolution and development of resistance to antibiotics. The questions he addresses include, deciphering the genetics of resistance evolution; probing the relationship between bacterial fitness and antibiotic resistance; and measuring the selection of resistance at very low levels of antibiotics, such as are found widely in the environment. Hughes is also engaged in a major European public-private partnership (ENABLE project) to develop novel antibiotics against Gram-negative bacterial pathogens.
Anna Zorzet, Coordinator ReAct Europe, Uppsala University
Anna Zorzet completed her PhD in medical microbiology with a focus on antibiotic resistance at Uppsala University in 2010. She then moved into the policy field when she joined ReAct, Action on Antibiotic Resistance in January 2011. She is currently heading ReAct’s Europe office and coordinating the program “Gathering and Translating Evidence” which translates scientific evidence into policy action on national, regional and global levels. Recent publications include work on overcoming scientific and structural bottlenecks in antibacterial discovery and development, and antibiotic use worldwide. She is also working with many regional and international networks on ABR, the WHO and is on the Stakeholder Advisory Board for the EU Joint Programming Initiative on AMR.
Thursday, February 12, 2015
5:30 p.m. Registration
6:00 p.m. Program
6.45 p.m. Q&A
8:00 p.m. Networking